As a physician leader who has overseen multiple large-scale healthcare systems, Ora Pescovitz, M.D., says her approach to major decisions always puts patients first.
"I always put our patients first, followed closely by our organization and the people who work for us. All three are in close proximity -- and all three are vitally important to protect," said Pescovitz, who is Eli Lilly and Company's Senior Vice President and U.S. Medical Leader.
Pescovitz is a pediatric endocrinologist and researcher who has published nearly 200 papers and books. In addition to her work at Lilly, she serves as an adjunct professor of pediatrics at the Indiana University School of Medicine. But Pescovitz’s contributions to IU and IU Health extend beyond her roles as clinician and researcher.
She provided leadership to both organizations for21 years, including CEO of Riley Hospital for Children, Interim Vice President for Research at IU and Executive Associate Dean for Research and Director of Pediatric Endocrinology at the IU School of Medicine.
Prior to her position at Lilly, Pescovitz spent five years at the University of Michigan, where she was the first female Executive Vice President for Medical Affairs and Health System CEO. That system is comprised of three hospitals, more than 120 health centers and clinics and the University of Michigan Medical School. In that role, she was responsible for $3.3 billion in revenue, $466 million in research, 1.9 million visits and 45,000 hospital stays.